Prab: CSV import

2024-03-06T03:44:09Z

CSV import

New page

[[File:Pimeclone.png|thumb|{{PAGENAME}}]]<br>'''Pimeclone''' is a [[sedative]] and [[anxiolytic]] drug in the [[cyclopyrrolone]] family, which includes similar drugs such as [[zopiclone]] and [[eszopiclone]]. It was developed in the late 1980s by the French pharmaceutical company [[Sanofi-Aventis]] and is used primarily in Europe for the treatment of [[insomnia]] and other sleep disorders.

==Pharmacology==
[[Pimeclone]] acts as a full [[agonist]] at the [[benzodiazepine]] receptor complex, producing effects similar to those of [[benzodiazepines]], such as [[sedation]], [[muscle relaxation]], and [[anxiolysis]]. It has a high [[bioavailability]] and a short [[half-life]], making it suitable for short-term treatment of acute [[insomnia]].

==Medical uses==
[[Pimeclone]] is primarily used for the short-term treatment of [[insomnia]]. It is also used off-label for the treatment of certain forms of [[anxiety]], particularly those associated with sleep disturbances. Due to its short [[half-life]], it is not recommended for long-term use or for the treatment of chronic insomnia.

==Side effects==
Common side effects of [[Pimeclone]] include drowsiness, dizziness, and impaired coordination. Less common side effects include memory impairment, hallucinations, and changes in mood or behavior. Long-term use can lead to [[tolerance]], [[dependence]], and [[withdrawal]] symptoms upon discontinuation.

==See also==
* [[Zopiclone]]
* [[Eszopiclone]]
* [[Cyclopyrrolones]]
* [[Benzodiazepine]]

{{Pharmacology-stub}}

[[Category:Drugs]]
[[Category:Anxiolytics]]
[[Category:Sedatives]]
[[Category:Cyclopyrrolones]]
[[Category:Sanofi-Aventis products]]

Pimeclone - Revision history

Prab: CSV import